文献速递慢性肾脏病水电解质与酸碱

南非CKD患者矿物质骨代谢标志物的种族差异

Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa.
PubMed 文献 · Kidney Int Rep · 2017-12-12

这项横断面多中心研究纳入南非约翰内斯堡3个肾脏中心的293例CKD患者(208例黑人、85例白人),比较矿物质骨代谢标志物的种族差异。黑人患者iPTH、碱性磷酸酶和25(OH)D3更高,FGF-23和血磷更低;黑人是严重继发性甲状旁腺功能亢进的独立相关因素。

要点

  • 南非CKD黑人患者iPTH、ALP、25(OH)D3高于白人,FGF-23和血磷更低。
  • 黑人种族与log PTH升高独立相关(β=0.488,P=0.01)。
  • 黑人发生严重甲状旁腺功能亢进的可能性是白人的3.08倍。

核心结论

  • 南非CKD人群中矿物质骨代谢标志物存在种族差异。

研究设计与样本

  • 横断面多中心研究,纳入南非约翰内斯堡3个肾脏中心的293例CKD患者(208例黑人、85例白人)。

主要发现

  • 黑人患者年龄显著低于白人(48.4±13.6岁 vs 57.1±15.5岁,P<0.001)。
  • 黑人iPTH中位数更高(498 pg/ml vs 274 pg/ml,P=0.03),碱性磷酸酶更高(122 U/L vs 103 U/L,P=0.03),25(OH)D3更高(26.8±12.7 ng/ml vs 22.7±12.2 ng/ml,P=0.01)。
  • 黑人FGF-23中位数更低(100 pg/ml vs 233 pg/ml,P=0.002),血磷更低(1.3±0.5 vs 1.5±0.5,P=0.001)。
  • 多因素分析中黑人种族与log PTH升高独立相关(β=0.488,P=0.01),与log FGF-23降低独立相关(β=-0.636,P=0.02)。
  • 黑人发生严重甲状旁腺功能亢进的可能性是白人的3.08倍(95%CI 1.51-6.30,P=0.002)。

临床怎么用

  • 评估南非CKD患者矿物质骨代谢标志物时应考虑种族差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Several studies showed that serum intact parathyroid hormone (PTH), phosphate, and vitamin D levels differ across races. These comparative studies were largely carried out between Caucasians and black Americans. However, little is known of the existence of these associations in an African population with chronic kidney disease (CKD). METHODS: This cross-sectional multicenter study involved 293 CKD patients from 3 renal units in Johannesburg, South Africa. RESULTS: The 293 CKD patients (208 blacks, 85 whites) had an overall mean age of 51.1 ± 13.6 years, and black patients were significantly younger than the white patients (48.4 ± 13.6 years vs. 57.1 ± 15.5 years; P < 0.001). Compared with whites, blacks had higher median intact PTH (498 [range: 37-1084] pg/ml vs. 274 [range: 131-595] pg/ml; P = 0.03), alkaline phosphatase (122 [range: 89-192] U/L vs. 103 [range: 74-144] U/L; p = 0.03), and mean 25 OH vitamin D3 (26.8 ± 12.7 ng/ml vs. 22.7 ± 12.2 ng/ml, P = 0.01) levels, whereas their median fibroblast growth factor (FGF) level was 23 (100 [range: 34-639] pg/ml vs. 233 [range: 80-1370] pg/ml; P = 0.002), and their mean serum phosphate (1.3 ± 0.5 vs. 1.5 ± 0.5; P = 0.001) levels were significantly lower. In multivariable analyses, black race was independently associated with increased log PTH (β = 0.488, P = 0.01) and decreased log FGF-23 (β = -0.636, P = 0.02). Similarly, blacks had a 3.08 times higher likelihood (95% confidence interval: 1.51-6.30; P = 0.002) of developing severe hyperparathyroidism than whites. CONCLUSION: This study highlighted the existence of racial differences in the circulating markers of mineral bone disorders in an African CKD population.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Waziri B, Duarte R, Dickens C, et al. Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa. Kidney Int Rep. 2017. PMID: 29854965. doi:10.1016/j.ekir.2017.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。